Evidence map›Paper›PMID 39204067›Full record

ArticleVaccines2024

Viral Vector-Based

Giuseppe Andreacchio, Ylenia Longo, Sara Moreno Mascaraque, Kartikan Anandasothy, Sarah Tofan, Esma Özün, Lena Wilschrey, Johannes Ptok, Dung T Huynh, Joen Luirink and 1 more

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giuseppe AndreacchioInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0009-0006-5072-0219
Ylenia LongoInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.
Sara Moreno MascaraqueInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.
Kartikan AnandasothyInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.
Sarah TofanInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.
Esma ÖzünInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.
Lena WilschreyInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.
Johannes PtokInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.
Dung T HuynhR&D Department, Abera Bioscience AB, 75184 Uppsala, Sweden.
Joen LuirinkR&D Department, Abera Bioscience AB, 75184 Uppsala, Sweden.
Ingo DrexlerInstitute of Virology, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0002-6903-9144

Funding

Deutsche Forschungsgemeinschaft DR632/2-1Deutsche Forschungsgemeinschaft GK1949/2European Union 812915
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cellular mediated immunityChlamydia trachomatismodified vaccinia virus Ankaravaccine

Identifiers

PMID39204067
PMCPMC11360449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.